Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUDEXA: Inhaled Budesonide vs. IV Dexamethasone for Postextubation Stridor
NCT02056379Unknown
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of budesonide in stridor, sponsored by Hospital Israelita Albert Einstein. Primary endpoint: Decrease of stridor and respiratory discomfort at 6 hours. Status: unknown.
02
Drugs
budesonide
03
Conditions
stridor
Beyond the preview
Go deeper on NCT02056379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056379.